Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inari Medical, Inc. stock logo
NARI
Inari Medical
$79.97
$79.97
$39.76
$79.99
$4.68B1.021.43 million shsN/A
Upstart Holdings, Inc. stock logo
UPST
Upstart
$73.57
+0.2%
$53.29
$20.60
$96.43
$7.00B2.376.89 million shs3.50 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inari Medical, Inc. stock logo
NARI
Inari Medical
0.00%0.00%0.00%0.00%+59.91%
Upstart Holdings, Inc. stock logo
UPST
Upstart
+0.25%+16.13%+44.31%+111.41%+218.90%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Inari Medical, Inc. stock logo
NARI
Inari Medical
0.5426 of 5 stars
1.10.00.00.01.42.50.6
Upstart Holdings, Inc. stock logo
UPST
Upstart
3.3653 of 5 stars
2.12.00.02.72.13.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inari Medical, Inc. stock logo
NARI
Inari Medical
2.14
Hold$69.22-13.44% Downside
Upstart Holdings, Inc. stock logo
UPST
Upstart
2.29
Hold$67.42-8.36% Downside

Current Analyst Ratings Breakdown

Latest UPST and NARI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeOverweight$75.00
6/12/2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$55.00
5/19/2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$70.00 ➝ $70.00
5/12/2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$42.00 ➝ $47.00
5/8/2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$15.00 ➝ $16.50
5/7/2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$108.00 ➝ $70.00
5/7/2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$105.00 ➝ $69.00
5/7/2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$70.00 ➝ $50.00
4/29/2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral$53.00 ➝ $53.00
4/14/2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$93.00 ➝ $42.00
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inari Medical, Inc. stock logo
NARI
Inari Medical
$493.63M9.48$0.09 per share906.95$8.07 per share9.91
Upstart Holdings, Inc. stock logo
UPST
Upstart
$636.53M11.00N/AN/A$6.94 per share10.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inari Medical, Inc. stock logo
NARI
Inari Medical
-$1.64M-$1.35N/A727.00N/A-13.68%-10.09%-6.60%N/A
Upstart Holdings, Inc. stock logo
UPST
Upstart
-$128.58M-$0.75N/A79.11N/A-9.20%-15.27%-4.60%8/5/2025 (Estimated)

Latest UPST and NARI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
Upstart Holdings, Inc. stock logo
UPST
Upstart
$0.19$0.30+$0.11-$0.03$201.08 million$213.37 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/AN/AN/AN/AN/A
Upstart Holdings, Inc. stock logo
UPST
Upstart
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/A
1.77
1.40
Upstart Holdings, Inc. stock logo
UPST
Upstart
N/A
0.56
0.56

Institutional Ownership

CompanyInstitutional Ownership
Inari Medical, Inc. stock logo
NARI
Inari Medical
90.98%
Upstart Holdings, Inc. stock logo
UPST
Upstart
63.01%

Insider Ownership

CompanyInsider Ownership
Inari Medical, Inc. stock logo
NARI
Inari Medical
10.60%
Upstart Holdings, Inc. stock logo
UPST
Upstart
16.67%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inari Medical, Inc. stock logo
NARI
Inari Medical
80058.54 million52.34 millionOptionable
Upstart Holdings, Inc. stock logo
UPST
Upstart
1,19395.14 million79.28 millionOptionable

Recent News About These Companies

Upstart: An AI Fintech Gem
Fintech Stock Breaking Above Key Resistance Levels

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Inari Medical stock logo

Inari Medical NASDAQ:NARI

$79.97 0.00 (0.00%)
As of 02/19/2025

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Upstart stock logo

Upstart NASDAQ:UPST

$73.57 +0.18 (+0.25%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$73.54 -0.02 (-0.03%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California.